x
Filter:
Filters applied
- EMAS Position Statements and Clinical Guides
- Schenck-Gustafsson, KarinRemove Schenck-Gustafsson, Karin filter
- Erel, C TamerRemove Erel, C Tamer filter
- BazedoxifeneRemove Bazedoxifene filter
EMAS Position Statements and Clincial Guides
1 Results
- Research Article
EMAS clinical guide: Selective estrogen receptor modulators for postmenopausal osteoporosis
MaturitasVol. 71Issue 2p194–198Published online: November 24, 2011- Santiago Palacios
- Mark Brincat
- C. Tamer Erel
- Marco Gambacciani
- Irene Lambrinoudaki
- Mette H. Moen
- and others
Cited in Scopus: 17Osteoporosis and the resulting fractures are major public health issues as the world population is ageing. Various therapies such as bisphosphonates, strontium ranelate and more recently denosumab are available. This clinical guide provides the evidence for the clinical use of selective estrogen modulators (SERMs) in the management of osteoporosis in postmenopausal women.
